Johnson & Johnson named Tom Cavanaugh to lead Innovative Medicine as Jennifer Taubert retires after more than 21 years with J ...
Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s ...
Eli Lilly and Company beats earnings, boosts 2026 guidance on GLP-1 drugs Mounjaro/Zepbound. Click here to read my most ...
Six people who were highly allergic to peanuts can tolerate the nut after receiving a faecal transplant, reports a study ...
BROADEN2 Phase 2b AD trial nearly six months ahead of anticipated timeline, with data expected by year-end 2026 ...
Two newly published papers underscore the need for increased awareness, caregiver education, and preparedness to help ensure timely use of epinephrine during severe allergic reactions ...
A massive analysis of immune cells in human tissue is yielding clues to the root causes of lung and autoimmune diseases.
AbbVie Inc. stock fell 6.2% after a 52-week high despite strong Q2 earnings; Rinvoq and Elahere sales surged. Click for this ...
Cirrus deepens expansion into Singapore and the Asia-Pacific region through collaboration with Singapore Eye Research Institute and Duke-NUS Medical School’s Centre for Vision Research to support ...
LOTTE Holdings Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Metaphore Biotechnologies, Inc. (Headquarters: Cambridge, MA, USA; CEO: Angela ...
AbbVie Inc. reported second quarter profit and sales that topped Wall Street’s expectations, driven by strong demand across ...
New research led by scientists at La Jolla Institute for Immunology (LJI) and the University of Liverpool (UOL) provides the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results